NASDAQ: OTLK
Outlook Therapeutics Inc Stock

$1.57+0.01 (+0.64%)
Updated Apr 30, 2025
OTLK Price
$1.57
Fair Value Price
-$0.80
Market Cap
$50.27M
52 Week Low
$0.87
52 Week High
$9.25
P/E
-0.34x
P/B
-1x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$46.81M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.34
Operating Cash Flow
-$67M
Beta
1.14
Next Earnings
May 14, 2025
Ex-Dividend
N/A
Next Dividend
N/A

OTLK Overview

Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with IPCA Laboratories Limited; Laboratorios Liomont, S.A. de C.V.; BioLexis Pte. Ltd.; and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine OTLK's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More

Zen Rating Component Grades

F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
OTLK
Ranked
#348 of 462

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important OTLK news, forecast changes, insider trades & much more!

OTLK News

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OTLK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OTLK ($1.57) is overvalued by 296.63% relative to our estimate of its Fair Value price of -$0.80 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
OTLK ($1.57) is not significantly undervalued (296.63%) relative to our estimate of its Fair Value price of -$0.80 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
OTLK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OTLK due diligence checks available for Premium users.

Valuation

OTLK fair value

Fair Value of OTLK stock based on Discounted Cash Flow (DCF)

Price
$1.57
Fair Value
-$0.80
Undervalued by
296.63%
OTLK ($1.57) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OTLK ($1.57) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OTLK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

OTLK price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.34x
Industry
-162.28x
Market
29.18x

OTLK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-1x
Industry
4.45x

OTLK's financial health

Profit margin

Revenue
$0.0
Net Income
$17.4M
Profit Margin
0%
OTLK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$17.0M
Liabilities
$67.3M
Debt to equity
-1.34
OTLK's short-term liabilities ($48.24M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OTLK's long-term liabilities ($19.06M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OTLK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OTLK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.0M
Investing
$0.0
Financing
$1.7M
OTLK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

OTLK vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
OTLKD$50.27M+0.64%-0.34x-1.00x
ANEB$49.71M+2.54%-4.32x3.32x
PEPGD$51.33M+2.61%-0.55x0.43x
PMVP$51.41M-1.00%-0.87x0.29x
ICCC$48.69M-0.61%-20.85x1.77x

Outlook Therapeutics Stock FAQ

What is Outlook Therapeutics's quote symbol?

(NASDAQ: OTLK) Outlook Therapeutics trades on the NASDAQ under the ticker symbol OTLK. Outlook Therapeutics stock quotes can also be displayed as NASDAQ: OTLK.

If you're new to stock investing, here's how to buy Outlook Therapeutics stock.

What is the 52 week high and low for Outlook Therapeutics (NASDAQ: OTLK)?

(NASDAQ: OTLK) Outlook Therapeutics's 52-week high was $9.25, and its 52-week low was $0.87. It is currently -83.03% from its 52-week high and 80.46% from its 52-week low.

How much is Outlook Therapeutics stock worth today?

(NASDAQ: OTLK) Outlook Therapeutics currently has 32,017,179 outstanding shares. With Outlook Therapeutics stock trading at $1.57 per share, the total value of Outlook Therapeutics stock (market capitalization) is $50.27M.

Outlook Therapeutics stock was originally listed at a price of $683.20 in Jun 14, 2016. If you had invested in Outlook Therapeutics stock at $683.20, your return over the last 8 years would have been -99.77%, for an annualized return of -53.21% (not including any dividends or dividend reinvestments).

How much is Outlook Therapeutics's stock price per share?

(NASDAQ: OTLK) Outlook Therapeutics stock price per share is $1.57 today (as of Apr 30, 2025).

What is Outlook Therapeutics's Market Cap?

(NASDAQ: OTLK) Outlook Therapeutics's market cap is $50.27M, as of May 1, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Outlook Therapeutics's market cap is calculated by multiplying OTLK's current stock price of $1.57 by OTLK's total outstanding shares of 32,017,179.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.